miR-1248 enhances bortezomib-induced autophagy by targeting MEF2C/p38-MAPK signaling in multiple myeloma - Top-Institutions - MDSpire

miR-1248 enhances bortezomib-induced autophagy by targeting MEF2C/p38-MAPK signaling in multiple myeloma

  • By

  • Wei Wang

  • Rong-juan Zhang

  • Ming-shuai Ma

  • Xiao-min Shi

  • Qing Zhang

  • Chong Li

  • Zhi-hua Zhang

  • Chang-lai Hao

  • June 26, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology

  • #2

    University of Birmingham
    University of Birmingham

    Birmingham, UK

    Key Differentiators

    • Hematology

Original Source(s)

miR-1248 enhances bortezomib-induced autophagy by targeting MEF2C/p38-MAPK signaling in multiple myeloma

  • by Wei Wang, Rong-juan Zhang, Ming-shuai Ma, Xiao-min Shi, Qing Zhang, Chong Li, Zhi-hua Zhang, Chang-lai Hao

  • June 26, 2026

Related Content

Immune regulation in mitochondrial transfer: knowledge structure and emerging trends from a bibliometric perspective

ESMO Breast Cancer 2026 Highlights: Saci-IO HR+

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss results from the Saci-IO HR+ trial, which were presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

  • 1 min
Effectiveness of a Home-Based and Group-Based Tele-Exercise Program for Breast Cancer Survivors: Pilot Randomized Controlled Trial